← Eichor
Study identifier: NCT03139786 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Follow-up of a Cohort of Patients With Aortic Valve Bicuspidia

Condition: Aortic Valve, Bicuspid  ·  Sponsor: Centre Hospitalier Universitaire, Amiens

PhaseN/A
Planned participants232
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aortic valve bicuspidia (BVA) is a congenital condition corresponding to the presence of 2 sigmoids instead of 3. This is the most common cardiac congenital anomaly affecting 0.5 to 2% of the population The general rule. BVA may be associated with structural damage to the ascending aorta, which exposes BVA patients to a risk of developing ascending aortic aneurysm and acute aortic accidents. Recent data from the literature have revealed that the natural history of BVA is marked by a possible development towards significant valvulopathy and / or an ascending aortic aneurysm often requiring surgical treatment. However, the natural history of bicuspid disease remains poorly understood and the prognostic factors for progression to severe valvulopathy and / or aneurysmal dilatation of the ascending aorta remain to be determined.

This description comes directly from the study's public registry record.

Talk to the study team

Christophe TRIBOUILLOY, PhD  ·  +33322455885  ·  tribouilloy.christophe@chu-amiens.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU Amiens PicardieAmiens, Picardie, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03139786